首页 | 本学科首页   官方微博 | 高级检索  
检索        

生物等效性试验健康受试者筛选流程的优化
引用本文:李坤,张晶莹,古利,刘杏,马培志,张伟.生物等效性试验健康受试者筛选流程的优化[J].中国临床药理学杂志,2021(3):298-301.
作者姓名:李坤  张晶莹  古利  刘杏  马培志  张伟
作者单位:河南省人民医院/郑州大学人民医院/河南大学人民医院药学部
基金项目:国家自然科学基金资助项目(81803357)。
摘    要:目的 探讨如何提高生物等效性试验健康受试者筛选期的工作效率.方法 试验甲给予受试者根据各个检查项目等待人数自由分流的筛选方法;试验乙给予对部分检查项目进行先后顺序限定,并要求研究者在发现受试者某项检查结果异常后,应及时终止其继续参加其他检查的筛选方法.比较2个试验中受试者在某项检查不合格时合并有其他项目检查的情况.结果...

关 键 词:生物等效性  临床试验  受试者招募  筛选流程  优化

Optimization of screening process for healthy subjects in bioequivalence trials
LI Kun,ZHANG Jing-ying,GU Li,LIU Xing,MA Pei-zhi,ZHANG Wei.Optimization of screening process for healthy subjects in bioequivalence trials[J].The Chinese Journal of Clinical Pharmacology,2021(3):298-301.
Authors:LI Kun  ZHANG Jing-ying  GU Li  LIU Xing  MA Pei-zhi  ZHANG Wei
Institution:(Department of Pharmacy,Henan Provincial People's Hospital,Zhengzhou University People's Hospital,Henan University People's Hospital,Zhengzhou 450003,Henan Province,China)
Abstract:Objective To investigate how to improve the efficiency of screening healthy subjects in bioequivalence test. Methods The trial A applied a screening method of free triage according to the number of subjects waiting for each inspection item, while trial B adopted a screening method in which the sequence of several inspection items was limited and the researchers were required to terminate subject’s participation in screening immediately if any abnormal test results appeared. The situation of combining other items when a certain inspection was unqualified was compared between two groups. Results The incidence of trial A that subjects failed weight, vital signs, inquiry and physical examination but combined with other inspection items was higher than that of trial B. During the screening process, trial A was found to have a phenomenon that multiple abnormal examination results occurred in a same subject,which led to the waste of medical resources. After optimizing the screening process, trial B could preferentially eliminate unqualified subjects in efficient, low-cost and non-invasive examination programs. Thus the rights of subjects were protected preferably and the costs of clinical trials screening are reduced. Conclusion The subjects screening process of trial B is superior to trial A as a whole, which is beneficial for the smooth development of clinical trial recruitment.
Keywords:bioequivalence  clinical trial  subject recruitment  screening process  optimization
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号